355 related articles for article (PubMed ID: 19024136)
1. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India.
Mehndiratta MM; Mehndiratta P; Phul P; Garg S
J Pak Med Assoc; 2008 Nov; 58(11):627-31. PubMed ID: 19024136
[TBL] [Abstract][Full Text] [Related]
2. [The decreased level of plasma carnitine in patients with epilepsy].
Belousova ED
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
[TBL] [Abstract][Full Text] [Related]
3. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012.
Cheng M; Tang X; Wen S; Yue J; Wang H
Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073
[TBL] [Abstract][Full Text] [Related]
4. A case of hyperammonaemic encephalopathy due to valproic acid.
Prins MC; van Meijel JJ
Neth J Med; 2011 Sep; 69(9):389-91. PubMed ID: 21978982
[TBL] [Abstract][Full Text] [Related]
5. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
Panda S; Radhakrishnan K
J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid induced hyperammonaemic encephalopathy.
Amanat S; Shahbaz N; Hassan Y
J Pak Med Assoc; 2013 Jan; 63(1):72-5. PubMed ID: 23865136
[TBL] [Abstract][Full Text] [Related]
8. Valproate-associated hyperammonemic encephalopathy.
Wadzinski J; Franks R; Roane D; Bayard M
J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
[TBL] [Abstract][Full Text] [Related]
9. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
[TBL] [Abstract][Full Text] [Related]
10. [Valproate-induced hyperammonemic encephalopathy in a patient with Sjögren's syndrome].
Nakazato Y; Ando S; Yamamoto T; Tamura N; Shimazu K
Rinsho Shinkeigaku; 2004 Oct; 44(10):682-5. PubMed ID: 15568484
[TBL] [Abstract][Full Text] [Related]
11. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
Velioğlu SK; Gazioğlu S
Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
[TBL] [Abstract][Full Text] [Related]
12. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
Chopra A; Kolla BP; Mansukhani MP; Netzel P; Frye MA
Gen Hosp Psychiatry; 2012; 34(3):290-8. PubMed ID: 22305367
[TBL] [Abstract][Full Text] [Related]
13. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
Larsen EP; Ostergaard JR
Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
[TBL] [Abstract][Full Text] [Related]
14. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
Hamed SA; Abdella MM
Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid-induced encephalopathy in very long course treated patients.
Rousseau MC; Montana M; Villano P; Catala A; Blaya J; Valkov M; Allouard Y; Bugni E
Brain Inj; 2009 Nov; 23(12):981-4. PubMed ID: 19831495
[TBL] [Abstract][Full Text] [Related]
16. Valproate-induced hyperammonemic encephalopathy: a brief review.
Lewis C; Deshpande A; Tesar GE; Dale R
Curr Med Res Opin; 2012 Jun; 28(6):1039-42. PubMed ID: 22587482
[TBL] [Abstract][Full Text] [Related]
17. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?
Latour P; Biraben A; Polard E; Bentué-Ferrer D; Beauplet A; Tribut O; Allain H
Hum Psychopharmacol; 2004 Apr; 19(3):193-203. PubMed ID: 15079854
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for hyperammonemia in pediatric patients with epilepsy.
Yamamoto Y; Takahashi Y; Imai K; Mishima N; Yazawa R; Inoue K; Itoh K; Kagawa Y; Inoue Y
Epilepsia; 2013 Jun; 54(6):983-9. PubMed ID: 23409971
[TBL] [Abstract][Full Text] [Related]
19. [Valproate-induced hyperammonemic encephalopathy].
Granel B; Gavaret M; Le Baut X; Sautereau N; Rodriguez D; Rossi P; Bagnères D; Demoux AL; Francès Y
Rev Med Interne; 2011 Jun; 32(6):e72-5. PubMed ID: 20633966
[TBL] [Abstract][Full Text] [Related]
20. Incidence, Presentation, and Risk Factors for Sodium Valproate-Associated Hyperammonemia in Neurosurgical Patients: A Prospective, Observational Study.
Woo PYM; Woo AWY; Lam SW; Ko NMW; Ho JWK; Chu ACH; Kwan MCL; Chan Y; Wong HT; Chan KY
World Neurosurg; 2020 Dec; 144():e597-e604. PubMed ID: 32916358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]